Skip to main content
MJHS
Navigation
Journal Navigation
Article Navigation

The research type of an article tag

Epidemiological data and diagnosis pitfalls in aggressive extranodal non-Hodgkin’s lymphomas: current issues
Dumitrita Urescu1,2*, Vasile Musteața1,2, Nina Sghibneva-Bobeico1,2, Maria Robu2, Larisa Musteața2, Victor Munteanu1
https://doi.org/10.52645/MJHS.2022.4.10
Non-Hodgkin's lymphoma is a group of malignant tumors that develop from hematopoietic cells located outside the medullary. They are one of the most common forms of hemoblastosis. Non-Hodgkin lymphoma develops in people of all ages. Morbidity of non-Hodgkin lymphoma increases with age reaching its highest level in people over 50 years of age.
Risk management - component part of the quality assurance system of pharmaceutical care
Nicoleta Cheptanari-Birta*†, Stela Adauji†, Mihail Brumărel†
https://doi.org/10.52645/MJHS.2022.4.09
In the pharmaceutical field, the quality management is a priority and the risk management is a valuable component of an effective quality system. It involves anticipating hazards and controlling risk through a process of risk awareness, reduction, and review. The aim of this paper was to reveal the usefulness of modern risk management strategies and to assess the impact of risk management in the provision of quality services by community pharmacies.
Impact of drainage technique on surgical treatment of ureteropelvic junction obstruction in adults
Urinary drainage is a key part of ureteropelvic junction obstruction treatment. Both external and internal drainage methods have been widely used for many years, but there is now relevant research comparing these methods and their impact on surgical outcomes in adults. The aim of the current research was to assess the efficacy and safety of two different types of urinary drainage on adult pyeloplasty.
Contemporary surgical options in large benign prostatic hyperplasia treatment
Alexei Plesacov1,2†*, Ivan Vladanov1,2†, Vitalii Ghicavii1,2†
https://doi.org/10.52645/MJHS.2022.4.06
Specialists are currently interested in the method of choice for surgical treatment in patients with enlarged benign prostate hyperplasia (> 80 cm3). The introduction of laser and bipolar technologies for benign prostate hyperplasia surgery has allowed effective treatment regardless of the size of the prostate gland.
Predisposing factors for surgical complications in chronic prostatitis and fibrosis of the prostate
Artur Colța*†, Vitalii Ghicavîi†
https://doi.org/10.52645/MJHS.2022.4.05
Prostatitis is an inflammatory process of the prostate, which continues to be considered one of the most common urological diseases in men under 45. Predisposing factors such as trophic, microcirculatory, and congestive disorders contribute to the onset and development of the inflammatory process in the prostate, as do risk factors such as the urethral catheter, urethrocystoscopy, endoscopic surgery for infection, and deterioration of the integrity of the urethral epithelium. The purpose of this study was to determine the impact of chronic inflammation and fibrosis of the prostate on urodynamics and local prostatic microcirculation and to evaluate the efficacy of conservative treatment.
Clinical patterns and complete blood count parameters in young patients with primary myelofibrosis in the prefibrotic stage
Nina Sghibneva-Bobeico1,2*, Vasile Musteata1,2, Maria Robu1,2, Lidia Jalba1, Larisa Musteata2, Ala Dorogan1, Cristina Dudnic1, Elena Covalschi1
https://doi.org/10.52645/MJHS.2022.4.04
Primary myelofibrosis is a rare myeloproliferative neoplasm that affects 0.2-1.5 people per 100,000. As a rule, the diagnosis is confirmed after 60 years, but recently, hematologists around the world have encountered the problem of primary myelofibrosis in young people. The classic manifestations of myelofibrosis are characterized by splenomegaly, cytopenia, and bone marrow fibrosis, but in patients younger than 40 years, the diagnosis is most often made in the prefibrotic stage of the neoplasm. The aim of the paper is to identify and evaluate the clinical and hematological features of primary myelofibrosis in young patients in the prefibrotic stage.
Impact of comorbidities on the clinical and ultrasound features of psoriatic arthritis
Psoriatic arthritis (PsA) is a chronic musculoskeletal and cutaneous inflammatory disease that affects about 20-30% of patients with psoriasis. In addition to musculoskeletal and cutaneous manifestations, patients with PsA have a higher prevalence of comorbidities compared to the general population. More than half of patients with PsA have at least one comorbidity, with up to 40% of patients having more than three comorbidities. PsA has a particularly strong association with metabolic diseases and, as a result, with cardiovascular diseases (CVD).